octaplasLG, Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
7680697800027
CH-69780
Pulver
Associated product:
OCTAPLASLG groupe sanguin AB subst sèche c solv
1 / 3
google
Article details
- Package size
- -
- Selling units
- unbekannt
- Measure
- Blutgruppe AB (1 Durchstechflasche mit Pulver und 1 Beutel mit Lösungsmittel, Transferset und Zubehör)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
- | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
Authorization holder
Octapharma AG
8853 Lachen SZ
Authorization information
- Swissmedic authorization number
- 69780
- Drug name
- octaplasLG, Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
- Galenic form
- PULMI
- ATC Code
- B05AA
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 12/11/2024
- Authorization expiration date
- 11/11/2029
- IT Number
- 06.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- OCTAPLASLG groupe sanguin AB subst sèche c solv
- Description (DE)
- OCTAPLASLG Blutgruppe AB Trockensub c Solv
- Market launch
- 12/11/2024
- Narcotic (BTM)
- No
Other package sizes (3)
None
None LEER
GTIN: None
None
None LEER
GTIN: None
None
None LEER
GTIN: None